log in
Back

WSG Task Force Team

Verrill  

Legal Services | Maine, USA

www.verrill-law.com
tel: +207 774 4000 | fax: +207 774 7499
One Portland Square | Portland | Maine | 04101 | USA

Meet The Team


Eric Altholz

Eric D. AltholzPartner

  • Employee Benefits & Executive Compensation
  • ERISA Litigation

Tawny Alvarez

Tawny L. AlvarezPartner

  • Breweries, Distilleries & Wineries
  • Business & Commercial Litigation

Robert Brooks

Robert C. BrooksPartner

  • Construction
  • Labor & Employment


Anthony Calcagni

Anthony M. CalcagniPartner

  • Energy
  • Real Estate

Roger Clement

Roger A. Clement, Jr.Partner

  • Bankruptcy
  • Commercial Law

Scott Connolly

Scott J. ConnollyPartner

  • Employment & Labor


Douglas Currier

Douglas P. CurrierPartner

  • Alternative Dispute Resolution
  • Higher Education

Regina Flaherty

Regina M. FlahertyPartner

  • Business & Corporate
  • Commercial Lending

Benjamin Ford

Benjamin E. FordPartner

  • Business & Commercial Litigation
  • Franchise & Dealership


John Giffune

John P. GiffunePartner

  • Alternative Dispute Resolution
  • Construction

Kathryn Graber

Kathryn G. GraberPartner

  • Commercial Lending
  • Real Estate

Christopher Graham

Christopher M. GrahamPartner

  • Business & Corporate
  • Business Law


Kate Heffernan

Kate Gallin HeffernanPartner

  • Academic & Clinical Research
  • Health Care

Nathaniel Hull

Nathaniel R. HullPartner

  • Bankruptcy & Creditors' Rights
  • Litigation & Trial

Cheryl Johnson

Cheryl L. JohnsonPartner

  • Business & Corporate
  • Private Funds & Advisors


Robert Laplaca

Robert LaplacaPartner

  • Litigation & Trial
  • Promotion Law

Christopher Lockman

Christopher S. LockmanPartner

  • Bankruptcy & Creditors' Rights
  • Employee Benefits & Executive Compensation

Suzanne Meeker

Suzanne E. MeekerPartner

  • Employee Benefits & Executive Compensation
  • Health Care Reform Response Team


Jacqueline Rider

Jacqueline W. RiderPartner

  • Higher Education
  • Private Clients & Fiduciary Services

A. Robert Ruesch

A. Robert RueschPartner

  • Alternative Dispute Resolution
  • Construction

Latest Alerts


A ‘Healthy’ Approach to Possible Commercial Lease Defaults in the Age of Coronavirus (COVID-19)
Verrill, March 2020

As COVID-19 cases mount across the country, the inability to perform commercial lease obligations due to unforeseen circumstances has moved to the forefront. In contract-speak, unforeseen circumstances that lead to non-performance by a party are known as “force majeure” events. In these uncertain times, the constant refrain from world leaders – “we are all in this together”— serves as an important call for action, and undoubtedly, landlords and tenants will need to work cooperatively and creatively to navigate this new landscape...

read more

Is the Coronavirus Pandemic a Force Majeure?
Verrill, March 2020

The coronavirus disease pandemic is an ongoing shock to the U.S. economic system and every-day life. The construction industry is on the front line of the tumult. Earlier this week, Boston Mayor Marty Walsh ordered the stoppage of construction projects within the City of Boston. The City of Cambridge has now followed suit. In other communities, projects have and will see permitting, inspection, and monitoring capabilities diminish in light of directives for public employees to work from home. Worldwide manufacturing slowdowns and stoppages will almost certainly create material supply and delivery issues...

read more

Due to COVID-19, Federal Agencies Relax Requirements Regarding the Provision of Telehealth Services
Verrill, March 2020

In the past few days, in an effort to help keep Medicare beneficiaries healthy during the COVID-19 pandemic, key federal agencies within the U.S. Department of Health and Human Services (“HHS”) and the U.S. Department of Justice, Drug Enforcement Administration (“DEA”), announced they were relaxing certain requirements that relate to the provision of telehealth services to Medicare beneficiaries and other patients...

read more

COVID-19: FDA Clinical Trial Guidance
Verrill, March 2020

On March 18, 2020, the U.S. Food & Drug Administration (“FDA”) published guidance for clinical trial sponsors, investigators, and institutional review boards (“IRBs”) on conducting clinical trials in the midst of the COVID-19 pandemic. In the guidance, FDA outlines important considerations for assuring the safety of trial participants, maintaining compliance with good clinical practice, and minimizing risks to trial integrity...

read more

Employer Obligations under the Revised Families First Coronavirus Response Act (H.R. 6201)
Verrill, March 2020

On March 18, 2020, President Trump signed into law the Families First Coronavirus Response Act (the “Act”) in response to COVID-19. Among other provisions, the Act gives a broad group of employees the right to emergency paid sick leave and also expands protections under the Family and Medical Leave Act (“FMLA”). This summary focuses on the impact to most private employers from the paid sick leave and expanded FMLA provisions, which take effect on April 2, 2020. Further guidance for employers in the form of regulations from the Department of Labor and Internal Revenue Service is expected...

read more

Congress Passes Emergency Paid Leave Laws in Response to Coronavirus Pandemic
Verrill, March 2020

On March 18, Congress passed and the President signed into law the Families First Coronavirus Response Act, a temporary measure designed to increase the availability of paid leave during a time when many employees are being directed to stay at home. The following is a brief summary of key elements of the new law that affect employers, including two weeks of mandatory paid sick leave and expanded paid FMLA leave for employees caring for children whose school or childcare provider has been closed due to the virus. Both the paid sick leave and the expanded paid FMLA leave provisions are temporary and the requirements end December 31, 2020...

read more

COVID-19 Expanded Access Template
Verrill, March 2020

We are aware that many companies and health care providers are working to expedite the transfer of investigational drugs that may be helpful in treating patients suffering from COVID-19. Although these expanded access arrangements are not required to be and are not always documented in written agreements, there can be benefits to both parties (company and treatment provider) to memorializing the circumstances of the provision of an investigational drug. To that end, we have created a simple Memorandum of Understanding template that may be useful to companies and providers seeking to document these arrangements quickly and efficiently in light of the current public health emergency...

read more

To Test or Not to Test: Employer Considerations Amid COVID-19 Pandemic
Verrill, March 2020

  Q: I am concerned about employees coming to work with a fever—can I test employees’ temperatures before allowing them to work to avoid spreading the coronavirus? Verrill’s View: Maybe—but there are many factors to consider. Generally, taking an employee’s temperature would be a restricted medical examination, but employers may have more flexibility due to COVID-19’s “pandemic” status. However, if you are considering taking an employee’s temperature as a method to limit exposure among your workforce, it is important to consider the legal implications of doing so and balance them with the benefits...

read more

High-Deductible Health Plans can Cover Coronavirus Costs
Verrill, March 2020

Recognizing the need to eliminate potential administrative and financial barriers to testing for and treatment of the 2019 Novel Coronavirus (COVID-19), in Notice 2020-15, posted today on IRS.gov, the IRS advised that high-deductible health plans (HDHPs) can pay for COVID-19-related testing and treatment, without jeopardizing their status. This also means that an individual with an HDHP that covers these costs may continue to contribute to a health savings account (HSA)...

read more

Should Employers Recognize COVID-19 As A Work-Related Injury?
Verrill, March 2020

While we know that everyone is being bombarded with COVID-19 recommendations, advice, news and data, one area that appears to have been overlooked is the question of whether COVID-19 infection, if acquired at work and due to the work performed, might result in a workers’ compensation injury. That specific question has not yet been litigated, but the best answer this writer can provide is “probably, yes”. Generally, in order for an injury or illness to be work-related, the condition must both “arise out of” and “in the course of” employment...

read more

Leave Sharing Programs: A Critical Bridge for Employees Affected by COVID-19
Verrill, March 2020

  The federal government may soon be providing paid leave assistance to employees affected by COVID-19. In the meantime, however, employers that maintain leave sharing programs can leverage those programs to help soften the financial impact on employees forced to miss work because of COVID-19. Leave sharing programs allow employees to donate their accrued paid time off for use by other employees affected by a medical emergency or major disaster. Leave sharing programs are not based on any provision in the Internal Revenue Code but rather on guidance from the Internal Revenue Service, primarily Revenue Ruling 90-29...

read more

COVID-19: Updated FAQs
Verrill, March 2020

Employers across the country are struggling with how to support their employees and their customers, and also to keep their business afloat, as the cry for social isolation to curb the spread of the novel COVID-19 (coronavirus) grows stronger. There are a lot of complicated issues that we are trying to sort through in a moment of crisis and the landscape continues to change. Legislation is being proposed at both the federal and state level, which is intended to address employee rights with respect to staying at home, right to continued compensation from their employer and/or their right to unemployment compensation...

read more

The Coronavirus: FAQs for Employers
Verrill, March 2020

We’ve been here before. Remember the H1N1 outbreak of 2009? That little bug originated outside of Mexico City. As the virus spread, governments issued travel warnings and schools were on notice to be extra vigilant. There was even a quarantined cruise ship and a run on surgical masks. Sound familiar? The most important lesson from the H1N1 outbreak of 2009 is that while it was scary then, we hardly remember it now. Just as in 2009, it makes sense to take some reasonable precautions in the event COVID-19 becomes more of a factor...

read more

All articles submitted by Verrill

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2020